129 related articles for article (PubMed ID: 16725008)
41. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
42. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications.
Ozcan A; Shen SS; Zhai QJ; Truong LD
Am J Clin Pathol; 2007 Aug; 128(2):245-54. PubMed ID: 17638658
[TBL] [Abstract][Full Text] [Related]
43. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal cell carcinoma and not surrogates for each other.
Tollefson MK; Thompson RH; Sheinin Y; Lohse CM; Cheville JC; Leibovich BC; Kwon ED
Cancer; 2007 Aug; 110(4):783-90. PubMed ID: 17594714
[TBL] [Abstract][Full Text] [Related]
44. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
[TBL] [Abstract][Full Text] [Related]
45. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of erythropoietin expression in human renal cell carcinoma.
Michael A; Politi E; Havranek E; Corbishley C; Karapanagiotou L; Anderson C; Relph K; Syrigos KN; Pandha H
BJU Int; 2007 Aug; 100(2):291-4. PubMed ID: 17617137
[TBL] [Abstract][Full Text] [Related]
47. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification.
Pignot G; Elie C; Conquy S; Vieillefond A; Flam T; Zerbib M; Debré B; Amsellem-Ouazana D
Urology; 2007 Feb; 69(2):230-5. PubMed ID: 17275070
[TBL] [Abstract][Full Text] [Related]
48. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
[TBL] [Abstract][Full Text] [Related]
49. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
[TBL] [Abstract][Full Text] [Related]
50. Peroxiredoxin I expression in tongue squamous cell carcinomas as involved in tumor recurrence.
Yanagawa T; Omura K; Harada H; Ishii T; Uwayama J; Nakaso K; Iwasa S; Koyama Y; Onizawa K; Yusa H; Yoshida H
Int J Oral Maxillofac Surg; 2005 Dec; 34(8):915-20. PubMed ID: 15955662
[TBL] [Abstract][Full Text] [Related]
51. Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma.
Matusan K; Dordevic G; Stipic D; Mozetic V; Lucin K
J Surg Oncol; 2006 Sep; 94(4):325-31. PubMed ID: 16917865
[TBL] [Abstract][Full Text] [Related]
52. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
[TBL] [Abstract][Full Text] [Related]
53. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK
J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
[TBL] [Abstract][Full Text] [Related]
54. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
55. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
[TBL] [Abstract][Full Text] [Related]
56. [Expression of oxidative stress proteins in the clear-cell renal cell carcinoma].
Tian MJ; Li YY; Luo CQ; Lv ML; Yang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):851-5. PubMed ID: 22863595
[TBL] [Abstract][Full Text] [Related]
57. Peroxiredoxins, thioredoxin, and Y-box-binding protein-1 are involved in the pathogenesis and progression of dialysis-associated renal cell carcinoma.
Fushimi F; Taguchi K; Izumi H; Kohno K; Kuwano M; Ono M; Nakashima Y; Takesue T; Naito S; Oda Y
Virchows Arch; 2013 Oct; 463(4):553-62. PubMed ID: 23907567
[TBL] [Abstract][Full Text] [Related]
58. Mucinous tubular and spindle cell carcinoma of kidney and problems in diagnosis.
Sarsik B; Sımşır A; Karaarslan S; Sen S
Turk Patoloji Derg; 2011 May; 27(2):116-26. PubMed ID: 21630197
[TBL] [Abstract][Full Text] [Related]
59. [Sonography--the most important study in the early detection of renal cell carcinoma].
Rauschmeier H
Urologe A; 1986 Nov; 25(6):325-8. PubMed ID: 3544449
[TBL] [Abstract][Full Text] [Related]
60. 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.
Soini Y; Haapasaari KM; Vaarala MH; Turpeenniemi-Hujanen T; Kärjä V; Karihtala P
Int J Clin Exp Pathol; 2011 Mar; 4(3):267-75. PubMed ID: 21487522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
